Designed and executed a Risk Management Plan (RMP) for a new chemotherapy product.
Coordinated between regulatory affairs and clinical teams for data validation.
Prepared periodic safety update reports (PSURs) aligned with EMA standards.
Reduced post-marketing risk incidents through proactive monitoring strategies.
Earned “Best Safety Initiative” recognition at company award event.